How Much Could COVID-19 Vaccines Cost the U.S. After Commercialization?

This analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compares the average price paid by the federal government for the COVID-19 bivalent boosters to the estimated average commercial prices across different scenarios.

Read the full post on Reports on Health Insurance and Health Care Costs from the Kaiser Family Foundation

Reports on Health Insurance and Health Care Costs from the Kaiser Family Foundation